论文部分内容阅读
为了比较独特的口服治疗计划对住院的急性肺炎患者的疗效,作在7个研究中心选择18岁以上成人147例进行研究。病人和方法全部患者均符合下列条件:①有下呼吸道感染的的临床症状,如胸痛、咳嗽和脓痰等;②X 线胸片示急性炎症浸润;③脓痰及支气管肺标本含革兰阴性细菌、葡萄球菌或肺炎双球菌。将患者随机为两组:氟嚓酸组75例,男55、女20例,平均年龄68.1(26～98)岁,均经口吸或胃管给予氟嗉酸400mg/12h 治疗;
In order to compare the efficacy of a unique oral treatment program for hospitalized patients with acute pneumonia, 147 adult patients over the age of 18 were selected for study at seven centers. Patients and Methods All patients met the following criteria: ① clinical symptoms of lower respiratory tract infection, such as chest pain, cough and purulent sputum; ② chest X-ray showed acute inflammatory infiltrates; ③ purulent sputum and bronchial lung specimens containing gram-negative bacteria Staphylococcus, or Streptococcus pneumoniae. The patients were randomly divided into two groups: 75 patients in the Fluoric Acid group, 55 males and 20 females, with an average age of 68.1 (26-98) years old. All patients were treated with 400 mg / 12h Fluoro acid by oral inhalation or gastric tube.